BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao L, Cheng H, Jiang Q, Li H, Wu Z. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging (Albany NY). 2020;12:4573-4591. [PMID: 32167932 DOI: 10.18632/aging.102913] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Niu C, Yang N, Liu C, Zou SS, Zhu S. Biomarker discovery and application-An opportunity to resolve the challenge of liver cancer diagnosis and treatment. Pharmacol Res 2023;189:106674. [PMID: 36702425 DOI: 10.1016/j.phrs.2023.106674] [Reference Citation Analysis]
2 Perne MG, Sitar-Tăut AV, Alexescu TG, Ciumărnean L, Milaciu MV, Coste SC, Vlad CV, Cozma A, Sitar-Tăut DA, Orăşan OH, Crăciun A. Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics (Basel) 2023;13. [PMID: 36899960 DOI: 10.3390/diagnostics13050816] [Reference Citation Analysis]
3 Song Y, Zhang YY, Yu Q, Chen T, Wei CG, Zhang R, Hu W, Qian XJ, Zhu Z, Zhang XW, Shen JK. A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma. Front Oncol 2023;13:1123141. [PMID: 36824129 DOI: 10.3389/fonc.2023.1123141] [Reference Citation Analysis]
4 Xu L, Chen L, Zhang B, Liu Z, Liu Q, Liang H, Chen Y, Chen X, Leng C, Zhang B. Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors. Front Immunol 2023;14:1115706. [PMID: 36761721 DOI: 10.3389/fimmu.2023.1115706] [Reference Citation Analysis]
5 Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology 2023. [PMID: 36680397 DOI: 10.1097/HEP.0000000000000237] [Reference Citation Analysis]
6 Liu L, Wang Q, Zhao X, Huang Y, Feng Y, Zhang Y, Fang Z, Li S. Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma. Front Oncol 2023;13:1131892. [PMID: 36890811 DOI: 10.3389/fonc.2023.1131892] [Reference Citation Analysis]
7 Wang H, Zhang Y, Yan L, Lv Q, Lu J, Yun B. Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma. Int J Immunopathol Pharmacol 2022;36:3946320221132986. [PMID: 36217828 DOI: 10.1177/03946320221132986] [Reference Citation Analysis]
8 Sun Z, Chen G, Wang L, Sang Q, Xu G, Zhang N. APEX1 promotes the oncogenicity of hepatocellular carcinoma via regulation of MAP2K6. Aging (Albany NY) 2022;14. [PMID: 36205565 DOI: 10.18632/aging.204325] [Reference Citation Analysis]
9 Chen Y, Qin Y, Wu Y, Wei H, Wei Y, Zhang Z, Duan T, Jiang H, Song B. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging. Front Immunol 2022;13:973153. [DOI: 10.3389/fimmu.2022.973153] [Reference Citation Analysis]
10 Liu J, Lu J, Li W, Mao W, Lu Y. Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma. Front Genet 2022;13:900380. [DOI: 10.3389/fgene.2022.900380] [Reference Citation Analysis]
11 Zhang H, Jiang PJ, Lv MY, Zhao YH, Cui J, Chen J. OGG1 contributes to hepatocellular carcinoma by promoting cell cycle-related protein expression and enhancing DNA oxidative damage repair in tumor cells. J Clin Lab Anal 2022;:e24561. [PMID: 35723423 DOI: 10.1002/jcla.24561] [Reference Citation Analysis]
12 Kong Y, Chen H, Chen M, Li Y, Li J, Liu Q, Xiong H, Guo T, Xie Y, Yuan Y, Zhang XL. Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. Front Oncol 2022;12:855952. [PMID: 35392238 DOI: 10.3389/fonc.2022.855952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Marin JJG, Romero MR, Herraez E, Asensio M, Ortiz-Rivero S, Sanchez-Martin A, Fabris L, Briz O. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems. Semin Liver Dis 2022;42:87-103. [PMID: 34544160 DOI: 10.1055/s-0041-1735631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Pascale RM, Simile MM, Calvisi DF, Feo CF, Feo F. S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent. Cells 2022;11:409. [PMID: 35159219 DOI: 10.3390/cells11030409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Miick R, Minimo C, Bombonati A. Hepatocellular Carcinoma Pathology. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_3] [Reference Citation Analysis]
16 Chen G, Zhang Z, Li Y, Wang L, Liu Y. LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG. J Oncol 2021;2021:3624306. [PMID: 34876904 DOI: 10.1155/2021/3624306] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Sun W, Hu C, Wang T, Wang J, Zhang J, Gao F, Ou Q, Tian H, Jin C, Xu J, Zhang J, Xu GT, Lu L. Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 2021;11:744331. [PMID: 34796110 DOI: 10.3389/fonc.2021.744331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Farhana A, Koh AE, Tong JB, Alsrhani A, Kumar Subbiah S, Mok PL. Nanoparticle-Encapsulated Camptothecin: Epigenetic Modulation in DNA Repair Mechanisms in Colon Cancer Cells. Molecules 2021;26:5414. [PMID: 34500845 DOI: 10.3390/molecules26175414] [Reference Citation Analysis]
19 Qing X, Xu W, Zong J, Du X, Peng H, Zhang Y. Emerging treatment modalities for systemic therapy in hepatocellular carcinoma. Biomark Res 2021;9:64. [PMID: 34419152 DOI: 10.1186/s40364-021-00319-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Pan PJ, Liu JX. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma. World J Clin Cases 2021; 9(22): 6287-6299 [PMID: 34434995 DOI: 10.12998/wjcc.v9.i22.6287] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Chen Y, Zhao H, Xiao Y, Shen P, Tan L, Zhang S, Liu Q, Gao Z, Zhao J, Zhao Y, Guo Y, Feng Y. Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer. Aging (Albany NY) 2021;13:16248-66. [PMID: 34135128 DOI: 10.18632/aging.203154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Liu Z, Li J, Hu X, Xu H. Helicobacter pylori-induced protein tyrosine phosphatase receptor type C as a prognostic biomarker for gastric cancer. J Gastrointest Oncol 2021;12:1058-73. [PMID: 34295557 DOI: 10.21037/jgo-21-305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pan X, Li B, Zhang G, Gong Y, Liu R, Chen B, Li Y. Identification of RORγ as a favorable biomarker for colon cancer. J Int Med Res 2021;49:3000605211008338. [PMID: 33947261 DOI: 10.1177/03000605211008338] [Reference Citation Analysis]
24 Huang T, Wang YJ, Huang MT, Guo Y, Yang LC, Liu XJ, Tan WY, Long JH. LINC00470 accelerates the proliferation and metastasis of melanoma through promoting APEX1 expression. Cell Death Dis 2021;12:410. [PMID: 33875645 DOI: 10.1038/s41419-021-03612-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lu S, Cai S, Peng X, Cheng R, Zhang Y. Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma. Front Immunol 2021;12:636614. [PMID: 33868261 DOI: 10.3389/fimmu.2021.636614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Miick R, Minimo C, Bombonati A. Hepatocellular Carcinoma Pathology. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_3-1] [Reference Citation Analysis]
27 Cai Y, Zheng Q, Yao DJ. Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma. World J Clin Cases 2020; 8(17): 3774-3785 [PMID: 32953853 DOI: 10.12998/wjcc.v8.i17.3774] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Zheng R, Zhu HL, Hu BR, Ruan XJ, Cai HJ. Identification of APEX2 as an oncogene in liver cancer. World J Clin Cases 2020; 8(14): 2917-2929 [PMID: 32775374 DOI: 10.12998/wjcc.v8.i14.2917] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
29 Yu Q, Gao K. CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma. Mol Med Rep 2020;22:2245-52. [PMID: 32705212 DOI: 10.3892/mmr.2020.11336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Cabral LKD, Tiribelli C, Sukowati CHC. Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity. Cancers (Basel) 2020;12:E1576. [PMID: 32549224 DOI: 10.3390/cancers12061576] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 15.3] [Reference Citation Analysis]